Impact of sacubitril/valsartan versus ramipril on total heart failure events in the PARADISE-MI trial

Pfeffer, M. A. et al. (2022) Impact of sacubitril/valsartan versus ramipril on total heart failure events in the PARADISE-MI trial. Circulation, 145(1), pp. 87-89. (doi: 10.1161/CIRCULATIONAHA.121.057429) (PMID:34797725)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Petrie, Professor Mark and McMurray, Professor John
Authors: Pfeffer, M. A., Claggett, B., Lewis, E. F., Granger, C. B., Køber, L., Maggioni, A. P., Mann, D., McMurray, J. J.V., Rouleau, J.-L., Solomon, S. D., Steg, P. G., Berwanger, O., Cikes, M., De Pasquale, C. G., Fernandez, A., Filippatos, G., Jering, K., Landmesser, U., Menon, V., Prof Merkely, B., Petrie, M. C., Petrov, I., Schou, M., Senni, M., Sim, D., van der Meer, P., Lefkowitz, M., Zhou, Y., Wang, Y., and Braunwald, E.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Circulation
Publisher:American Heart Association
ISSN:0009-7322
ISSN (Online):1524-4539
Published Online:19 November 2021

University Staff: Request a correction | Enlighten Editors: Update this record